Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS in Pediatric and Teenage MDD During COVID-19
NCT04780152Phase 3Unknown
- Sponsor
- National Institute of Neurology and Neurosurgery
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by National Institute of Neurology and Neurosurgery. Primary endpoint: Children Depression Inventory at 12 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT04780152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780152.